July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them from the Heart Rhythm Society (HRS) 2021 meeting. For more information on the meeting, visit https://heartrhythm.com.
Late Breaking Clinical Trials and Registry
Thursday, July 29, 8:15 AM - 9:15 AM CDT
• STROKE VT Trial: Safety And Efficacy Of Periprocedural Direct Oral Anticoagulant Versus Aspirin Use For Reduction Of The Risk Of Cerebrovascular Events In Patients Undergoing Ventricular Tachycardia Radiofrequency Catheter Ablation. Presented by Dhanunjaya R. Lakkireddy.
• A Randomized Pilot Study Of Perioperative Spinal Cord Stimulation To Prevent Post-CABG Atrial Fibrillation: 30-day Safety And Efficacy Outcomes. Presented by Alexander B. Romanov.
• Clinical Outcomes Of Left Bundle Branch Area Pacing Compared To Right Ventricular Pacing: Results From The Geisinger-Rush Conduction System Pacing. Presented by Parikshit S. Sharma.
• A Randomized Trial Of Early First-Line Catheter Ablation For Ventricular Tachycardia: Results From The Pan-Asia United States Prevention Of Sudden Cardiac Death Trial (PAUSE-SCD). Presented by Roderick Tung.
Late Breaking Clinical Innovations
Thursday, July 29, 12:45 PM - 1:45 PM CDT
• Continuous ECG Monitoring Versus Mobile Telemetry: A Comparison Of Arrhythmia Diagnostics Between Human And Algorithm Dependent Systems. Presented by Mark Willcox, M.D.
• Leadless LV Stimulation With Wise-CRT System - Initial Experience In New U.S. Centers: Results From Phase I Of Solve-CRT Study (non-randomized, Roll-in Phase).Presented by Jagmeet P Singh.
• Ultralow Temperature Cryoablation For Atrial Fibrillation, Primary Outcome Results On Efficacy And Safety. The Cryocure-2 Study. Presented by Tom De Potter.
• Analysis Of Behavior Of Af Sources With Electrographic Flow Mapping. Presented by David E. Haines.
Late Breaking Clinical Trials Updates
Friday, July 30, 9:30 AM - 10:30 AM CDT
• Oral Contraceptive Use And The Risk Of Cardiac Events In Women With Congenital Long QT Syndrome. Presented by Ilan Goldenberg.
• Early Rhythm Control Therapy In Patients With Atrial Fibrillation And Heart Failure (EAST – AFNET 4). Presented by Andreas Rillig.
• Economic Outcomes Of Ablation Versus Drug Therapy In CABANA. Presented by Derek Chew.
• Safety And Effectiveness Of Multi-site Pacing In Initial Non-responders To Conventional Cardiac Resynchronization Therapy. Presented by Samir F. Saba.
Late Breaking Science
Friday, July 30, 12:45 PM - 1:45 PM CDT
• Sinus Node Sparing Hybrid Thoracoscopic Ablation Outcomes In Patients With Inappropriate Sinus Tachycardia (Susruta-IST Registry). Presented by Dhanunjaya R. Lakkireddy.
• Left Bundle Branch Optimized Cardiac Resynchronization Therapy (LOT-CRT): Results From International LBBAP Collaborative Study Group. Presented by Marek Jastrzebski.
• Ganglionated Plexus Ablation To Prevent Atrial Fibrillation (GANGLIA-AF Trial). Presented by Min-young Kim.
• First-in-human Clinical Experience With A Novel 4-D ICE Catheter During Catheter Ablation And LAA Closure Procedures. Presented by Vivek Y. Reddy.
Related HRS Conference Coverage:
VIDEO: Multi-Site Pacing Effective in Initial Nonresponders to Conventional Cardiac Resynchronization Therapy — Interview with Samir Saba, M.D.
Northwestern Medicine First in U.S. to Use Live 3D Intracardiac Echo for EP Procedure
AliveCor and Acutus Partner to Evaluate Arrhythmia Management and Treatment
Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions
VIDEO: EP Trends and New Technology From Biosense Webster at HRS 2021
Biosense Webster Showcases New Data and Latest Innovations at Heart Rhythm 2021
New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients With Atrial Fibrillation
Biotronik Implantable Cardiac Monitor Receives Prestigious Industry Award
July 30, 2024 
